Premature termination codon suppression therapy could be used to treat a range of genetic disorders. Here the authors present a high-throughput cell-based assay to identify anticodon engineered tRNAs with high suppression activity.
- John D. Lueck
- Jae Seok Yoon
- Christopher A. Ahern
